Webinars and Sponsored Roundtables — Register Now
Tuesday, April 28, 2026, 12:00 PM–1:00 PM ET
Discover how next-day comprehensive genomic profiling (CGP) is possible with the Oncomine Comprehensive Assay Plus on the Genexus System—delivering both speed and accuracy.
Webinar presenters Jane Bayani, MHSc, PhD, Assistant Professor and Co-Director, Diagnostic Development, Ontario Institute for Cancer Research, Canada, and Nicola Normanno, MD, Scientific Director, IRCCS Romagnolo Institute for the Study of Tumors, Italy, and Morten Grauslund, PhD, Molecular Biologist, Department of Pathology, Rigshospitalet/Copenhagen University Hospital, Copenhagen, Denmark.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Thermo Fisher Scientific. For Research Use Only. Not for use in diagnostic applications.
Thursday, April 30, 2026, 11:00 AM–12:00 PM ET
Hear an expert discuss how Memorial Sloan Kettering Cancer Center (MSKCC) is utilizing
the oncoReveal® Nexus 21-gene panel to redefine turnaround time and actionable insights
in cancer care. Dr. Ewalt shares a perceptive look at the clinical need for rapid, front-line NGS sequencing, and how a unique, purpose built targeted NGS panel (Pillar Biosciences’ oncoReveal Nexus 21 gene Panel) was developed, validated and implemented clinically by Memorial Sloan Kettering Cancer Center (MSK-REACT) to complement their current comprehensive genomic profiling (CGP) approach.
Webinar presenter Mark Ewalt, MD, Associate Medical Director for Laboratory Operations for Diagnostic Molecular Pathology in the Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, MSKCC.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Pillar Biosciences.
Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Product Spotlight
Sysmex America
| Company | Sysmex America |
|---|---|
| Name of urinalysis instrument | Clinitek Novus Automated Urine Chemistry Analyzer |
| Contact | Pinak Patel |
| City, State | Lincolnshire, IL |
| Phone | 888-879-7639 |
| Website | |
| Type of instrument | urine chemistry |
| Instrument list price | — (available via purchase or lease) |
| First year instrument sold in the U.S. | 2015 |
| Approximate No. of units in clinical use in the U.S./outside the U.S. | >600/>57 (in Canada) |
| Foreign countries where company markets instrument | Canada |
| Country where instrument is designed/manufactured | U.S. and United Kingdom/U.S. and United Kingdom |
| Human languages (other than English) supported | — |
| Intended urine sample volume per day | >50 |
| Dimensions (H×W×D) | 21 × 25 × 27 in. |
| Weight fully loaded with reagents/without reagents | —/93 lbs. |
| Power requirements | 100–240 VAC |
| Mean time between failure of instrument | 120 days |
| Events that cause instrument to lock or stop analysis | user ID failure, sampling error, consumables replacement/expiration, calibration failure |
| • Urine chemistry tests available on instrument in the U.S. | bilirubin (0.5–2.7 mg/dL), red blood cells (trace level), hemoglobin (0.013–0.3 mg/dL), glucose (36–820 mg/dL), ketone (3.6–156 mg/dL), leukocyte esterase (6–91 cells/µL), nitrite (positive/negative), pH (5.3–8.7), protein (10.8–1,000 mg/dL), specific gravity (1.000–1.099), urobilinogen (0.24–6.24 mg/dL) |
| • Color compensation pad included/Flagging thresholds customizable | yes/yes |
| • Test strip configuration | cartridge |
| • Calibration required after each test strip lot No. change | yes |
| • Frequency of customer-performed calibration/Form of calibration | with every new lot No. of Novus cassette loaded or same lot No. loaded and calibration is > 24 hours old/liquid |
| • How results are displayed for urine chemistry | semiquantitative |
| • Specific gravity correction for protein/glucose | no/no |
| • Microscopy/sediment technology | — |
| • Microscopy/sediment analysis parameters | — |
| • Flagging thresholds customizable | — |
| • Instrument eliminates amorphous crystal interference before sample analysis | — |
| • How results are displayed for microscopy/sediment | — |
| • Reporting format customizable | — |
| • No. of results that can be held in internal memory | — |
| Reagent shelf life/storage temp. for unopened containers of calibrator | —/2–8°C |
| Reagent shelf life/storage temp. for opened containers of calibrator | — |
| Reagent shelf life/storage temp. for unopened containers of control reagent | —/QC: 2–8°C; cassette: 15–30°C |
| Reagent shelf life/storage temp. for opened containers of control reagent | — |
| Reagent barcode-reading capability | yes, for all tests (can read Code 39, Code 128, more) |
| How often quality control samples are run | follow government regulations or accreditation requirements (can use other companies’ QC products) |
| Sample throughput per hour/Time to first result for chemistry | 240/— |
| Sample throughput per hour/Time to first result for microscopy/sediment | — |
| Analyzer has stat mode | no |
| FDA approved for body fluid analysis | no |
| Sample dilutions required for urinalysis/body fluid analysis | no/not applicable |
| Minimum width of sample tube/Minimum length of sample tube | 16 mm/95 mm |
| Conditions or substances that prevent a sample from being run | — |
| Means of sample ID entry | barcode scan, manual entry, worklist download from host, RFID for authentic entry of cassette lot |
| Built-in liquid-level sensing for samples | yes |
| Information that can be barcode scanned on instrument | operator identifier, specimen identifier, reagent lot No. |
| Compatible with laboratory automation systems | yes (Siemens Aptio, Abbott Accelerator a3600) |
| How LOINC codes for results are made available | website, e-mail query |
| Software includes reflex testing/cross-check functionality | yes/yes |
| Instrument automatically generates consolidated report* | no |
| Instrument archives patient data | yes (sample ID, test results) |
| Instrument connections to transfer information | data-management system that connects to LIS or EHR, or directly to LIS, EHR, or lab automation system |
| Interface standards or formats supported | ASTM 1394-91, ASTM 1381, HL7 version 3 |
| Bidirectional interface | yes, to other companies’ LISs and EHRs |
| Test results can be transmitted to LIS as soon as tests completed | yes |
| Connection to LIS/EHR to upload patient and QC results | LIS and EHR: direct serial, hospital network |
| Information included in transmission to data-management system | device unique identifier, operator ID, patient ID, specimen ID, result, QC identifier |
| Training included with instrument purchase | yes (virtual instructor-led training at customer site) |
| Approximate scheduled maintenance time required | 5–10 min. daily |
| Onboard diagnostics for troubleshooting | yes |
| Provide list of client sites to potential customers on request | yes (partial list of comparable sites with no restrictions regarding its use) |
| Clients restricted from sharing their experience with company or software | no |
| Distinguishing instrument features (supplied by company) | reagent cassette format with RFID that provides complete traceability and 14-day onboard stability; digital color camera that takes images of full light spectrum |
| *chemistry and microscopy results in one report; Note: a dash in lieu of an answer means company did not answer; question or question is not applicable | †marketed in the U.S. and Canada by Sysmex; marketed in other countries by Siemens Healthineers |